Mental Health
TOOLBOX
Filter
105
Featured
Language
Document type
No document type
69
Training Material
14
Manuals
12
Guidelines
4
Fact sheets
3
Resource Platforms
2
Studies & Reports
1
Countries / Regions
Ukraine
3
Syria
3
Russia
3
Nepal
2
Global
2
Western and Central Europe
2
Eastern Europe
2
South Sudan
2
Kenya
1
Middle East and North Africa
1
Authors & Publishers
World Health Organization WHO
48
World Health Organization
31
WHO
29
World Health Organization, UN High Commissioner for Refugees
6
World Health Organisation (WHO)
5
World Health Organization (WHO)
3
Organisation Mondiale de la Santé OMS
2
PAHO
2
Tarun Dua, Nicolas Clark, Neerja Chowdhary et al.
2
World Health Organitarion
2
Eastern Mediterranean Region
1
Gerald L. Klerman, Myrna M. Weissman et al.
1
Katie Dawson, Richard Bryant, Melissa Harper et al.
1
mGAP
1
mHGAP
1
Organisation Mondiale de la Santé OMS
1
Organización Panamericana de la Salud, et al.
1
Organización Panamericana de la Salud, Organización Mundial de la Salud
1
WHO, Columbia University in the city of New York
1
WHO, UNHCR
1
World Health Organization WHO, UNICEF
1
World Health Organization, UNHCR
1
Марк ван Оммерен, Ютаро Сетойя, Пітер Фентефогел et al.
1
Ніко Кларк, Тарун Дуа, Александра Фляйшманн et al.
1
Publication Years
Category
Clinical Guidelines
9
Capacity Building
4
Countries
4
Key Resources
1
Session outline •Introduction to psychoses. •Assessment of psychoses. •Management of psychoses. •Follow-up. •Review.
Q7. SCOPING QUESTION: In adults with moderate-severe depressive disorder, what is the effectiveness and safety of antidepressant medication (ADM) in comparison with psychological treatment? The WHO mhGAP programme’s existing guidelines recommend that either structured brief psychological treatm... more
Q5.SCOPING QUESTION: In individuals with psychotic disorders (including schizophrenia) who require long-term antipsychotic treatment, what is the safety and role of depot antipsychotic medication?
The new guide provides practical, first-line management recommendations for mental, neurological and substance use conditions. Contents include modules on assessing and managing conditions such as acute stress, grief, moderate-severe depressive disorder, post-traumatic stress disorder, epilepsy, and... more
В этом разделе «Руководства mhGAP по принятию мер в отношении психических и неврологических расстройств» приведены рекомендации по оценке и оказанию помощи при ост... more
Q15. SCOPING QUESTION: Is pharmacological intervention effective and safe for treatment of psychotic disorders in adolescents (including schizophrenia and bipolar disorder)?
It includes different activities for the different material provided in mhGAP
Session Outline •General Principles •Essentials of mental health care and clinical practice: Assessments •Essentials of mental health care and clinical practice: Management •Essentials of mental health care and clinical practice: Follow-up •Reviews
DEP supporting material • Person stories • Role plays – role plays 3 and 4 are extra material for supplementary activities • Multiple choice questions • Video links
This module aims to provide basic guidance on management of range of mental health complaints not coveredelsewhere in this guide. Some of these complaints may be similar to depression, but upon closer examamination are distinct from the conditions covered in this guide. Other mental health complaint... more
SUI supporting material • Person stories • Role plays • Multiple choice questions • Video link
Session outline •Introduction to dementia •Assessment of dementia •Management of dementia •Follow-up •Review
SUI supporting material • Person stories • Role plays • Multiple choice questions • Video link Activity 2: mhGAP SUI module – assessment and management
Q12. SCOPING QUESTION: In people with psychotic disorders, including schizophrenia and bipolar disorder, are recovery-oriented strategies enhancing vocational and economic inclusion (such as supported employment) feasible and effective?
“mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings” is a technical tool for implementation of the mhGAP Programme. The Intervention Guide has been developed through a systematic review of evidence, followed by an international consul... more
This module should always be used together with the mhGAP Intervention Guide for Mental, Neurological and Substance Use Disorders in Non-specialized Health Settings (WHO, 2010), which outlines relevant general principles of care and management of a range of other mental, neurological and substa... more
What can you expect? As a future facilitator your role will be to learn about the structure of mhGAP-IG, how to teach the materials and utilize opportunities to prastice facilitation and supervision skills. As a supervisor your role will be to serve as a point of reference for non-specialized heal... more
Q 10: In adults and children with epilepsy, which psychological interventions used as adjunctive therapies with antiepileptic drugs when compared to placebo/comparator produce benefits/harm in specified outcomes?